Member Info for LTinvestor

The value of the shares being bought and sold is pathetic in the grand scheme of things!

Sorry my mistake the figure is £230m.

Still it shows the worth of a properly run company with a product that people want to buy!!

In the Times today there is an article describing how two guys have sold their company to Unilever for £350M.

What does the company make? natural deodorant!

Our BOD have been beyond a joke for the best part of 20 years.

Hopefully the new board member can help turn things around.

At last an adult in the room

The massive strategic mistake that FUM has made is medicalising Eroxon for a specific demographic.

It has a far too high price point and is security protected in many retail outlets.

If it was marketed as a sexual enhancement that also helps ED and promoted on social media,things might be very different.

Please don’t make the same mistake with the female version.Women don’t have ED and .Why is it necessary to obtain regulatory approval?Sell it as an enhancement to sexual enjoyment not a medical solution to a physical problem.

Yes generic! what is wrong with comparing a generic with the absurd price of Eroxon?

If you goggle Eroxon there are pharmacies selling it for £28!

You can buy 4 Cialis tablets for under £8.

The price structure is all wrong.

What they have to communicate is that Eroxon is NOT an aphrodisiac and that you need to use it several times before it is effective.

I think the retail price is a big obstacle to repeat sales.

FUM must be proactive and make the news “leak “ out.The odd news story in the Express will not cut the mustered

If the formula of the gel used in the female study is similar to Eroxon why not allow it to be known that women now might like to use Eroxon .FUM could use various forms of social media influencers to plant the idea.Of course they won’t because they do not have the skill set to navigate the modern world.

This is a good solid statement. After many many years they have declared that they expect to be a profitable business within a year.AT LAST!

The reason is that when ever there is some positive news the day traders sell for there 8%.

This significant body of PI’s who have no interest in the long term prospects of the company have depressed the share price for years.

The reason that the company is not releasing a running commentary on the progress of Eroxon is because it has the effect of counterintuitively leading to the share price going down,and leading to many disappointed investors who buy into the news only to see their investment go down 10%!

That it takes a PI to share the latest positive news and stop the share price slide.

SHAME on you JB.

If only there was a mechanism to remove him.He has always been way out of his depth.

Don’t get me started on the CFO.

It is beyond my comprehension that punters can’t sit on their hands for a couple of weeks.

I am convinced that the investor presentation will be positive and there will be an upward revision in the share price.

As I have observed several times in the passed most PI’s never make a profit because they never buy or sell at the right time.

For the avoidance of doubt I bought a significant number of share in the placement at 7p. I could have tried to trade but resisted.Not trusting my timing.

I am waiting for the buyout that will surely come.

If the fickle IP’s don’t get a new RNS every other day they panic and sell.Its really pathetic

Make no mistake this news is massive. For it to be available on prescription it would have to have gone through the NICE process.

This will be free to those over 60.

Moreover it will be prescribed for those who are counter indicated for other treatments for ED.

I have commented many times about this share being traded,and that’s why it cannot achieve its true value.Just look what has happened this week,indeed first thing this morning.All those aspiring Warren Buffet’s thinking they were being very savvy , expecting to buy back at a much lower price.No doubt thinking there would be no news until April.

They have been caught out and can lament at leisure.

You call them ‘bone heads’ but this significant number of day traders are consistently undermining confidence in this share.They destroy any prospect of long term growth.Why would an institution invest only to see their investment walked down time and time again.

Look at LO who are sitting on a significant loss on the warrants that they exercised.

The CFO recognised that FUM is adversely affected by having such a large number of PI’s.

I don’t blame those who trade this share.Its a free market.

The only way this dilemma will be resolved is when a big pharma makes a bid.We are far nearer that conclusion with yesterdays news.

Please someone explain how the CFO is responsible for today’s share price.Today for example we had a very positive RNS: the result a 4% drop in the share price

Last year I listed all the very positive developments in this company’s history.The result a 40% drop in the share price since then.

It may well be the case that FUM could not raise other sources of finance and had to issue new shares,presumably to finance the USA efficacy trial.

In any normal scenario following the granting of FDA approval as the only over the counter treatment for erectile dysfunction this share would be 3 times its present price.

However the fundamental value is distorted by short term traders.

I think the only change will come about when the company is sold.The price will determine my profit after 15 years of frustration!!

I don’t agree with those heaping criticism on the CFO.It was not her that gave the disastrous interview after the interims.

What she did observe in an investor presentation was that there are too many PI’s holding shares in this company,this leads to the enormous volatility we witness constantly.

About 40% of the total shares are held by institutions.This leaves 60% in the hands of IP’s.

The catch 22 dilemma is that institutions cannot be persuaded to invest because of the volatility bought about by the 10% day traders.How to break this cycle is beyond my pay grade.

It is a sad fact that FUM in the last year has never been able to sustain a rally for more than about 5 days.

We LTH’s can only watch from the side lines in frustration as day traders make a few quid.

I still think that the Chinese failure still needs to play out(I think someone calculated that there may be some 2m shares to be offloaded)

Following this weeks RNS I am very confident that we LTH’s will be well rewarded.